发明名称 SELECTIVE MODULATION OF TUMOUR NECROSIS FACTOR RECEPTORS IN THERAPY
摘要 <p>This invention relates to the identification and characterization of specific cellular responses which are associated with tumor necrosis factor receptor 1 (TNFR1) and tumor necrosis factor receptor 1 (TNFR2). Selective modulation of these tumor necrosis factor receptors (TNFRs) Selective modulations of these responses may be useful in the promotion or inhibition of cell growth, for example, in the treatment of disease conditions, including cardiovascular and kidney diseases. Therapeutic methods employed selective TNFR1 and TNFR2 modulators are provided, along with screening methods for the identification of selective TNFR1 and TNFR2 modulators useful in such methods.</p>
申请公布号 CA2605253(A1) 申请公布日期 2006.10.19
申请号 CA20062605253 申请日期 2006.04.11
申请人 CAMBRIDGE ENTERPRISE LIMITED;YALE UNIVERSITY 发明人 BRADLEY, JOHN;POBER, JORDAN;MIN, WANG;CLARK, PAUL;KLUGER, MARTIN
分类号 G01N33/68;A61K38/19;A61K39/395;A61K48/00 主分类号 G01N33/68
代理机构 代理人
主权项
地址